STATE STREET CORP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$228,671,218
-9.1%
8,425,616
+2.9%
0.01%0.0%
Q2 2023$251,663,400
-16.3%
8,186,838
-1.8%
0.01%
-23.5%
Q1 2023$300,519,204
-53.2%
8,340,805
-48.6%
0.02%
-10.5%
Q4 2022$641,795,474
+101.6%
16,239,764
+105.0%
0.02%
-5.0%
Q3 2022$318,282,000
-1.0%
7,921,415
+3.6%
0.02%
+5.3%
Q2 2022$321,385,000
+6.3%
7,644,740
-1.5%
0.02%
+26.7%
Q1 2022$302,430,000
+7.2%
7,762,572
+9.7%
0.02%
+15.4%
Q4 2021$282,032,000
+33.7%
7,077,330
+21.3%
0.01%
+18.2%
Q3 2021$210,868,000
+5.7%
5,834,745
+19.9%
0.01%0.0%
Q2 2021$199,524,000
-2.4%
4,867,634
+3.9%
0.01%
-8.3%
Q1 2021$204,397,000
+73.2%
4,685,863
+98.7%
0.01%
+71.4%
Q4 2020$118,005,000
+175.5%
2,357,742
+131.6%
0.01%
+133.3%
Q3 2020$42,835,000
+2062.3%
1,018,194
+2395.6%
0.00%
Q2 2020$1,981,00040,8000.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$294,957,00088.74%
Vantage Consulting Group Inc 8,705,551$379,735,00076.23%
Memorial Sloan Kettering Cancer Center 2,680,644$116,930,00072.07%
HARVARD MANAGEMENT CO INC 10,714,284$467,357,00026.11%
ROBERT WOOD JOHNSON FOUNDATION 970,151$4,231,798,00021.59%
Brown University 381,759$16,652,00011.44%
Overbrook Management Corp 771,155$33,638,0007.48%
SpiderRock Advisors, LLC 778,800$34,236,0004.79%
Renaissance Capital LLC 452,948$19,758,0002.93%
Lagoda Investment Management, L.P. 104,835$4,573,0002.28%
View complete list of ROYALTY PHARMA PLC shareholders